Brief: BioNTech Holds 8.29% Stake In Ryvu Therapeutics
Jan 19 (Reuters) - Ryvu Therapeutics RVU.WA :
* BIONTECH NOW HOLDS 8.29% STAKE IN COMPANY FOLLOWING
REGISTRATION
OF J SERIES SHARES
Source text for Eikon: ID:nEM2Yzwnba
Further company coverage: RVU.WA 22UAy.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Signs Grant Agreement For Panacea-Novo Project With The National Center For Research And Development
Brief: Ryvu Therapeutics Q2 Net Loss 13.1 Million Zlotys
Brief: Ryvu Therapeutics "Dualis" Project Recommended For 22.2 Mln Zloty Subsidy
Brief: Ryvu Therapeutics Launches Early Clinical Development Services Business For Biotech And Pharma In Europe
Brief: Ryvu Therapeutics Says Panacea-Novo Project Recommended For Funding Of 106.7 Mln Zlotys